Estimating the Lifetime Health Outcomes of Type 2 Diabetes Mellitus (T2dm) Patients Inadequately Controlled on Metformin Plus Sulphonylurea Receiving Either Canagliflozin or Sitagliptin Using the UKPDS Outcomes Model V1.3
Value Health. 2014 Nov;17(7):A558.
doi: 10.1016/j.jval.2014.08.1838.
Epub 2014 Oct 26.